TY - THES
T1 - Clinical aspects of non-severe hemophilia: Focus on bleeding, joint and treatment outcomes
T2 - Focus on bleeding, joint and treatment outcomes
AU - Gouw, S.C.
AU - Kloosterman, F.R.
N1 - UvA
PY - 2023/5/25
Y1 - 2023/5/25
N2 - Hemophilia A and B are rare inherited bleeding disorders, caused by mutations in the F8 or F9 gene on the X-chromosome leading to a deficiency of coagulation factor VIII (FVIII) or coagulation factor IX (FIX), respectively. As a result, persons with decreased coagulation FVIII/IX levels have an increased bleeding tendency. Classification of disease severity is based on the endogenous FVIII/IX
AB - Hemophilia A and B are rare inherited bleeding disorders, caused by mutations in the F8 or F9 gene on the X-chromosome leading to a deficiency of coagulation factor VIII (FVIII) or coagulation factor IX (FIX), respectively. As a result, persons with decreased coagulation FVIII/IX levels have an increased bleeding tendency. Classification of disease severity is based on the endogenous FVIII/IX
UR - https://pure.uva.nl/ws/files/124605856/Licentieovereenkomst_medeondertekend_.pdf
UR - https://pure.uva.nl/ws/files/124605858/Stellingen.pdf
M3 - Phd-Thesis - Research and graduation internal
SN - 9789464830507
ER -
